- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatism in Canada
Total 708 results
-
Canadian Cancer Trials GroupEndocyte; Prostate Cancer CanadaActive, not recruiting
-
Ignacio Puche SanzChinese University of Hong Kong; UMC Utrecht; University of Padova; Medical University... and other collaboratorsNot yet recruitingProstate Cancer MetastaticSpain
-
Canadian Cancer Trials GroupCompleted
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
Mount Sinai Hospital, CanadaUnknownChronic Prostatitis With Chronic Pelvic Pain SyndromeCanada
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)Completed
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingProstate CancerCanada
-
NCIC Clinical Trials GroupS*BIOCompleted
-
Canadian Cancer Trials GroupOncolytics BiotechCompleted
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer Patients With OligometastasesCanada
-
University Health Network, TorontoNational Cancer Institute (NCI)TerminatedSarcoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Prostate CancerCanada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Medical Research Council; Eastern Cooperative... and other collaboratorsCompleted
-
Urotronic Inc.ClinLogix. LLCActive, not recruitingBenign Prostatic HyperplasiaUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompleted
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
Novartis PharmaceuticalsCompletedProstate CancerCanada, United States
-
NeoTract, Inc.CompletedBenign Prostatic HyperplasiaUnited States, Australia, Canada
-
CHU de Quebec-Universite LavalTerSera Therapeutics LLCRecruitingProstate Cancer | Radiotherapy Side Effect | Node; ProstateCanada
-
Canadian Urology Research ConsortiumFerring PharmaceuticalsTerminated
-
Canadian Cancer Trials GroupCanadian Cancer Clinical Trials Network; BC Cancer FoundationActive, not recruiting
-
CMX ResearchFerring PharmaceuticalsCompleted
-
Ignacio Puche SanzHospital Universitario Reina Sofia de CordobaRecruitingRecurrent Prostate Cancer | Prostate Cancer | CryotherapySpain
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
NCIC Clinical Trials GroupCompletedProstate CancerUnited States, Canada
-
CMX ResearchSanofiCompleted
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
University Health Network, TorontoActive, not recruiting
-
Queen's UniversityAllerganTerminatedChronic Pain Syndrome | ProstatitisCanada
-
Ontario Clinical Oncology Group (OCOG)NCIC Clinical Trials GroupCompleted
-
Centre hospitalier de l'Université de Montréal...McMaster University; Queen's University; London Health Sciences Centre; Canadian... and other collaboratorsActive, not recruiting
-
CMX ResearchSanofiCompleted
-
PfizerCompletedProstatic NeoplasmsUnited States, Spain, Germany, Canada, United Kingdom, Switzerland
-
PROCEPT BioRoboticsCompletedBenign Prostatic Hyperplasia (BPH)United States, Canada
-
AB ScienceCompletedMetastatic Castrate Resistant Prostate CancerItaly, Russian Federation, India, Canada, France, Malaysia
-
University of WashingtonCanary Foundation; Early Detection Research NetworkRecruiting
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
NCIC Clinical Trials GroupOncothyreon Canada Inc.Completed
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone Refractory Prostate CancerUnited States, Canada
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerCanada
-
British Columbia Cancer AgencyCanadian Institutes of Health Research (CIHR)Completed
-
QLT Inc.TerminatedProstatic HyperplasiaUnited States, Canada
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
Karolinska InstitutetUniversity Health Network, Toronto; University of Chicago; University of Illinois... and other collaboratorsCompletedProstate Cancer (Diagnosis)United States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerCanada
-
BayerRecruitingAdvanced Metastatic Castration-resistant Prostate Cancer | Prostate Specific Membrane Antigen (PSMA) ExpressionCanada, United Kingdom, Belgium
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom